Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | LLY | JNJ | ABBV | MRK |
| Company | Novo Nordisk A/S ADR | Eli Lilly and Company | Johnson & Johnson | Abbvie Inc | Merck & Company |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 103.91 | 757.05 | 155.90 | 174.34 | 100.33 |
| High | 106.24 | 761.28 | 157.12 | 178.86 | 101.79 |
| Low | 103.86 | 745.08 | 154.11 | 173.50 | 98.93 |
| Last | 105.06 | 748.01 | 155.17 | 176.95 | 99.18 |
| Change | +2.43 | -1.91 | -0.33 | +5.22 | -0.68 |
| % Change | +2.37% | -0.25% | -0.21% | +3.04% | -0.68% |
| Volume | 6,143,300 | 4,015,400 | 8,265,900 | 11,328,600 | 14,031,100 |
| 20-Day Average Volume | 6,818,175 | 5,623,750 | 7,503,385 | 7,929,735 | 11,329,165 |
| Previous Close | 102.63 | 749.92 | 155.50 | 171.73 | 99.86 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 107.35 | 800.80 | 156.37 | 184.56 | 100.37 |
| 20-Day Raw Stochastic | 39.33% | 18.62% | 38.65% | 30.20% | 44.21% |
| 20-Day Relative Strength | 39.62% | 33.58% | 43.01% | 42.48% | 37.10% |
| Weighted Alpha | -11.16 | +10.28 | +0.57 | +17.15 | -13.32 |
| Today's Opinion | 100% Sell | 56% Sell | 24% Sell | 24% Sell | 100% Sell |
| Previous Opinion | 100% Sell | 56% Sell | 24% Sell | 24% Sell | 100% Sell |
| Last Month's Opinion | 88% Sell | 24% Buy | 88% Buy | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/15/24 | +0.24% since 11/15/24 | +0.76% since 11/15/24 | +7.25% since 11/15/24 | +2.98% since 11/15/24 |
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 151.81 on 11/20/24 | 163.81 on 11/19/24 | 95.26 on 11/19/24 |
| High | 106.24 on 11/22/24 | 761.28 on 11/22/24 | 157.12 on 11/22/24 | 178.86 on 11/22/24 | 101.79 on 11/22/24 |
| 1-Month | |||||
| %Chg | -9.80% since 10/22/24 | -17.72% since 10/22/24 | -5.07% since 10/22/24 | -6.26% since 10/22/24 | -7.00% since 10/22/24 |
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 150.76 on 11/14/24 | 163.81 on 11/19/24 | 94.48 on 11/15/24 |
| High | 116.43 on 10/23/24 | 907.98 on 10/29/24 | 166.00 on 10/23/24 | 207.32 on 10/31/24 | 107.36 on 10/23/24 |
| 3-Month | |||||
| %Chg | -23.25% since 08/22/24 | -21.61% since 08/22/24 | -4.42% since 08/22/24 | -9.89% since 08/22/24 | -14.90% since 08/22/24 |
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 150.76 on 11/14/24 | 163.81 on 11/19/24 | 94.48 on 11/15/24 |
| High | 139.74 on 08/30/24 | 972.48 on 08/27/24 | 168.85 on 09/04/24 | 207.32 on 10/31/24 | 120.30 on 09/06/24 |
| 6-Month | |||||
| %Chg | -21.61% since 05/22/24 | -6.84% since 05/22/24 | +1.09% since 05/22/24 | +10.86% since 05/22/24 | -24.35% since 05/22/24 |
| Low | 99.42 on 11/18/24 | 711.40 on 11/18/24 | 143.71 on 05/29/24 | 153.58 on 05/30/24 | 94.48 on 11/15/24 |
| High | 148.15 on 06/25/24 | 972.53 on 08/22/24 | 168.85 on 09/04/24 | 207.32 on 10/31/24 | 134.63 on 06/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 471,460,128 | 710,097,856 | 373,590,880 | 312,695,424 | 250,889,200 |
| Shares Outstanding, K | 4,487,532 | 949,316 | 2,407,623 | 1,767,140 | 2,529,635 |
| Annual Sales | 33,724,300,000 | 34,124,100,000 | 85,159,000,000 | 54,318,000,000 | 60,115,000,000 |
| Annual Net Income | 12,150,770,000 | 5,240,400,000 | 35,153,000,000 | 4,863,000,000 | 365,000,000 |
| Last Quarter Sales | 10,511,240,000 | 11,439,100,000 | 22,471,000,000 | 14,460,000,000 | 16,657,000,000 |
| Last Quarter Net Income | 4,024,170,000 | 970,300,000 | 2,694,000,000 | 1,561,000,000 | 3,157,000,000 |
| 60-Month Beta | 0.42 | 0.43 | 0.53 | 0.63 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.90 on 11/06/24 | 1.18 on 10/30/24 | 2.42 on 10/15/24 | 3.00 on 10/30/24 | 1.57 on 10/31/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/15/24 | 10/30/24 | 10/31/24 |
| Most Recent Dividend | 0.362 on 08/16/24 | 1.300 on 11/15/24 | 1.240 on 11/26/24 | 1.550 on 10/15/24 | 0.770 on 09/16/24 |
| Next Ex-Dividends Date | 08/16/24 | 11/15/24 | 11/26/24 | 01/15/25 | 12/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 33.21 | 73.74 | 15.19 | 15.97 | 16.78 |